FR2963736B1 - Composition therapeutique comprenant un derive de galvinoxyl et de la propolis, et son utilisation contre les virus a capside lipidique, notamment les virus de l'herpes - Google Patents

Composition therapeutique comprenant un derive de galvinoxyl et de la propolis, et son utilisation contre les virus a capside lipidique, notamment les virus de l'herpes

Info

Publication number
FR2963736B1
FR2963736B1 FR1056523A FR1056523A FR2963736B1 FR 2963736 B1 FR2963736 B1 FR 2963736B1 FR 1056523 A FR1056523 A FR 1056523A FR 1056523 A FR1056523 A FR 1056523A FR 2963736 B1 FR2963736 B1 FR 2963736B1
Authority
FR
France
Prior art keywords
viruses
galvinoxyl
propolis
derivative
therapeutic composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR1056523A
Other languages
English (en)
Other versions
FR2963736A1 (fr
Inventor
Robert Vachy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR1056523A priority Critical patent/FR2963736B1/fr
Priority to EP11754743.0A priority patent/EP2603229A1/fr
Priority to PCT/IB2011/053543 priority patent/WO2012020370A1/fr
Publication of FR2963736A1 publication Critical patent/FR2963736A1/fr
Application granted granted Critical
Publication of FR2963736B1 publication Critical patent/FR2963736B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Insects & Arthropods (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Animal Husbandry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR1056523A 2010-08-10 2010-08-10 Composition therapeutique comprenant un derive de galvinoxyl et de la propolis, et son utilisation contre les virus a capside lipidique, notamment les virus de l'herpes Expired - Fee Related FR2963736B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR1056523A FR2963736B1 (fr) 2010-08-10 2010-08-10 Composition therapeutique comprenant un derive de galvinoxyl et de la propolis, et son utilisation contre les virus a capside lipidique, notamment les virus de l'herpes
EP11754743.0A EP2603229A1 (fr) 2010-08-10 2011-08-09 Derive de galvinoxyl pour son utilisation contre les virus a enveloppe lipoproteique, notamment les virus de l'herpes
PCT/IB2011/053543 WO2012020370A1 (fr) 2010-08-10 2011-08-09 Derive de galvinoxyl pour son utilisation contre les virus a enveloppe lipoproteique, notamment les virus de l'herpes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1056523A FR2963736B1 (fr) 2010-08-10 2010-08-10 Composition therapeutique comprenant un derive de galvinoxyl et de la propolis, et son utilisation contre les virus a capside lipidique, notamment les virus de l'herpes

Publications (2)

Publication Number Publication Date
FR2963736A1 FR2963736A1 (fr) 2012-02-17
FR2963736B1 true FR2963736B1 (fr) 2012-08-31

Family

ID=43608670

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1056523A Expired - Fee Related FR2963736B1 (fr) 2010-08-10 2010-08-10 Composition therapeutique comprenant un derive de galvinoxyl et de la propolis, et son utilisation contre les virus a capside lipidique, notamment les virus de l'herpes

Country Status (3)

Country Link
EP (1) EP2603229A1 (fr)
FR (1) FR2963736B1 (fr)
WO (1) WO2012020370A1 (fr)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3171100D1 (en) 1981-03-27 1985-08-01 Rudolf Schanze Process for separation of products containing propolis and products containing propolis
DE3279437D1 (en) 1982-12-01 1989-03-16 Zenon M Sosnowski Method for extracting propolis and water soluble dry propolis powder obtained thereby and cosmetic and pharmaceutical preparations containing same
YU45458B (en) 1987-10-05 1992-05-28 Vera Rozic Process for obtaining liquid ethanole extract of propolis
FR2659234B1 (fr) * 1990-03-12 1994-07-01 Fileco Sa Composition therapeutique contenant un compose phenol et de la propolis utile contre les virus a capside lipidique, notamment les virus de l'herpes.
EP0557404B1 (fr) * 1990-11-12 1996-05-15 Fileco UTILISATION ANTIVIRALE DE COMPOSE 2,6-DI-t-BUTYLPHENOL SUBSTITUE EN POSITION 4, NOTAMMENT VIS-A-VIS DES VIRUS DE L'HERPES ET DES PAPILLOMAVIRUS
JP2890212B2 (ja) * 1991-01-29 1999-05-10 有限会社野々川商事 化粧料
WO2002062361A1 (fr) * 2001-02-06 2002-08-15 Cherbuliez Theodore Composition antivirale contenant de la propolis et des huiles essentielles
KR20060007083A (ko) * 2004-07-14 2006-01-24 주식회사 마크로케어 람부탄 추출물을 함유하는 미백화장료 조성물 및 람부탄추출방법
FR2887249B1 (fr) * 2005-06-21 2007-09-28 Rdw Pharma Soc Par Actions Sim Compose d-glucopyranose 1-[3,5-bis(1,1-dimenthylethyl)-4- hydroxybenzoate] et ses derives, leur preparation et leurs utilisations
MY174362A (en) * 2006-11-27 2020-04-10 Univ Malaya Nephelium lappaceum extracts for cosmeceutical and nutraceutical applications
KR101393007B1 (ko) * 2007-11-30 2014-05-13 주식회사 코리아나화장품 람부탄 및 리치 추출물을 유효성분으로 함유하는 피부노화방지용 및 피부주름 개선용 화장료 조성물
FR2933616B1 (fr) * 2008-07-10 2011-08-19 Robert Vachy "compositions renfermant une association de propolis et d'un derive phenolique et leurs applications biologiques"

Also Published As

Publication number Publication date
FR2963736A1 (fr) 2012-02-17
WO2012020370A1 (fr) 2012-02-16
EP2603229A1 (fr) 2013-06-19

Similar Documents

Publication Publication Date Title
HRP20190504T1 (hr) Doza farmaceutskog pripravka i cjepiva u krutom obliku
BRPI0812738A2 (pt) Composto, sal farmceuticamente aceitável, composição farmacêutica, uso de um composto, e, método par ao tratamento de uma infecção viral em um humano
EP2471926A3 (fr) Oligodésoxynucléotides immunostimulateurs
IL223783B (en) Compound 1-converted indole for use in the treatment of a disease or condition, a pharmaceutical preparation containing the compound and use of the compound to prepare a medicine
IL234166B (en) Isoindoline compounds, a pharmaceutical composition containing it and its use in the preparation of a medicine
IL206952A (en) History of Aminodia Hydrothiazine, medicinal preparations containing them, and their use in the preparation of medicines
BR112014014262A2 (pt) nanopartículas; composição farmacêutica; método de administrar um ou mais agentes terapêuticos, profiláticos, e/ou diagnósticos a um paciente em necessidade dos mesmos e método de preparação das partículas.
IL202111A (en) Formulas for oral administration of amphotericin b and their use in the preparation of drugs for the treatment of infectious disease
IL199945A (en) Hydrochloric acid derivatives, pharmaceuticals containing them and their use in the preparation of drugs
IL212573A (en) Aryl Methyl Benzokinazulinone Compounds
BRPI1013394A2 (pt) "composto, composição farmacêutica, uso do composto, e, método para tratar um paciente infectado com virus da hepatite c."
IL232325A0 (en) 18-methyl-7,6-methylene-3-oxo-17-paragan-4-en-21, 17b-carbolactones, pharmaceutical preparations containing these compounds and their use for the treatment of endometrial disease
EP2532668A4 (fr) Dérivés de 2-hydroxytétrahydrothiénopyridine optiquement actifs, leur procédé de préparation et utilisation dans fabrication de médicament
IL213019A (en) Derivatives 1-Azo-3-Terroyl-Azoline, Pharmaceutical Preparations Containing and Using Them
FR2967674B1 (fr) Derives d'heteroarylsulfonamides, leur preparation et leur application en therapeutique humaine
BRPI0822885A2 (pt) Implemento para cuidado oral, método para administrar um agente ativo, e, kit para cuidado oral
SG10201506708UA (en) Method for preparing pharmaceutical compositions intended for oral administration comprising one or more active ingredients and the compositions comprising same
FR2945534B1 (fr) DERIVES DE CYCLOPENTAL[c]PYRROLE-2-CARBOXYLATES, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
CA2915027A1 (fr) Compositions et procedes d'administration de vaccins contre le virus de la dengue
MX2013013800A (es) Oligodesoxinucleotidos inmunoestimuladores.
HK1245334A1 (zh) 改善的用於人乳頭狀瘤病毒的疫苗及其使用方法
BR112014028315A2 (pt) mposto, métodos para introdução de uma molécula dentro do citosol de uma célula, para obter a morte de uma célula, para expressar uma molécula antigênica ou uma parte da mesma na superfície de uma célula, e para tratamento ou prevenção de uma doença, distúrbio ou infecção em um paciente, composição farmacêutica, célula ou uma população de células, e, kit
FR2933700B1 (fr) Derives de pyridino-pyridinones, leur preparation et leur application en therapeutique
BRPI1009392A2 (pt) "formulação farmacêutica, e, uso de uma quantidade farmaceuticamente eficaz de uma formulação farmacêutica."
IL231050A0 (en) Pyridines are converted in 4,5,6,7 tetrahydro-1hydrogen-pyrazolo[3,4-si], their use as medicine and medical preparations containing them

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20150430